All of the heparin lawsuits filed in federal courts throughout the country as a result of contaminated blood thinner will be transferred to Toledo, Ohio. The cases will be consolidated for pretrial litigation as part of a Federal procedure known as a multi-district litigation, or MDL. Continued
All Posts Tagged With: "Baxter"
HydraGlide Catheter Recall: Heparin Coating Contaminated
A voluntary recall was issued this week for HydraGlide Thoracic Drainage Catheters which were coated with heparin that may be contaminated with oversulfated chondroitin sulfate. The contaminant is the same chemical that led to the nationwide Baxter heparin recall in February 2008, which resulted in half of the U.S. supply of the blood thinner being removed from the market. Continued
FDA Urges Medical Providers to Double Check Supplies for Recalled Baxter Heparin
On May 9th, the FDA issued another statement to healthcare providers regarding the Baxter heparin recall that was issued on February 11th. Due to concerns that supplies of contaminated heparin may still be in storage, the FDA has urged surgeons, dialysis centers, hospitals and other healthcare providers to make sure that all of the recalled heparin has been removed and is no longer being used. Continued
Medtronic Recall as a Result of Contaminated Heparin
A Medtronic recall has been issued for various disposable cardiac bypass surgery devices which may be coated with heparin that is contaminated. The blood thinner may contain a fake ingredient known as oversulfated chondroitin sulfate. This is the same contaminant which has previously led to a nationwide Baxter recall for injectable heparin. Continued
Heparin Recall Lawsuits
Beginning around November 2007, the FDA started receiving a large number of reports involving adverse events associated with allergic-type reactions to heparin. Subsequent investigations have uncovered that a large portion of the heparin sold in the United States around this time was contaminated with a fake ingredient. In early 2008, a nationwide Baxter Heparin Recall was issued involving nearly half of the supply of injectible heparin sold in the U.S. Other forms of the blood thinner made from the same raw ingredients have also been recalled. Continued
